Milan J. Anadkat, MD, FAAD
SESSIONS
S018 Skinternal Medicine: An Update on Cutaneous Manifestations of Systemic Disease
Mar 27, 2026
•
12:00 AM - 12:00 AM
•
Four Seasons 3
U072 What is Safe to Use for Routine Dermatologic Disease if Your Patient Has Been Diagnosed with Cancer?
Mar 29, 2026
•
12:00 AM - 12:00 AM
•
Mile High 1A
DISCLOSURES
AbbVie – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Fees); Eli Lilly – Advisory Board(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Incyte Corporation – Investigator(Grants/Research Funding); Merus B.V. – Consultant (1099 relationship)(Fees); Novartis – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria), Investigator(Grants/Research Funding);